| BSE: 500488 | Sector: Health care |
| NSE: ABBOTINDIA | ISIN Code: INE358A01014 |
| BSE 00:00 | 23 Aug | 8786.90 |
53.10 (0.61%) |
OPEN
8790.00 |
HIGH
8801.00 |
LOW
8700.00 |
| NSE 00:00 | 23 Aug | 8790.85 |
-14.70 (-0.17%) |
OPEN
8899.50 |
HIGH
8899.50 |
LOW
8700.00 |
| OPEN | 8790.00 |
| PREVIOUS CLOSE | 8733.80 |
| VOLUME | 2872 |
| 52-Week high | 9400.00 |
| 52-Week low | 6900.00 |
| P/E | 38.51 |
| Mkt Cap.(Rs cr) | 18,672 |
| Buy Price | 8800.00 |
| Buy Qty | 1.00 |
| Sell Price | 9298.85 |
| Sell Qty | 1.00 |
Abbott India Ltd is one of the largest MNC pharma companies operating in India. It is a subsidiary of Abbott Laboratories of USA. Abbott Laboratories held 75% stake in Abbott India as on 31 March 2018. The company is engaged in the discovery development manufacture and marketing of pharmaceutical diagnostic nutritional and hospital products. They are having their presence in both OTC drugs and for...> More
| COMPANY INFORMATION | |||||||
| Chairman : | Munir Shaikh | ||||||
| Director : | Kaiyomarz Marfatia | ||||||
| Company Secretary : | Krupa Anandpara | ||||||
| Independent Director : | Krishna Mohan Sahni | ||||||
| Managing Director : | Ambati Venu | ||||||
| Whole Time Director & CFO : | Rajiv Sonalker | ||||||
| Independent Director : | Anisha Motwani | ||||||
| Director : | Jawed Zia | ||||||
| Addtnl Independent Director : | Sudarshan Jain | ||||||
| Additional Director : | Mark Murphy | ||||||
| AUDITOR : | S R B C & Co LLP | ||||||
| IND NAME : | Pharmaceuticals - Multinational | ||||||
| HOUSE NAME : | MNC Associate - Abbott | ||||||
| Registered office | |||||||
| Unit No 3 Corporate Park, Sion Trombay Road Chembur,Mumbai,Maharashtra-400071 | |||||||
| Ph : 91-22-67978888 | |||||||
| WEBSITE : http://www.abbott.co.in | |||||||
| E-mail : investorrelations.india@abbott.com | |||||||
